In colorectal cancer, inhibiting the activation of the Wnt signaling pathway can reduce the infiltration of Treg cells in the tumor and up-regulate the content of CD8+ T cells in the tumor, thereby enhancing the response to immunotherapy (51). The gene discussed is CD8A; the disease is neoplasm.